Notably, MAFLD demonstrates a close association with type 2 diabetes mellitus (T2DM) and obesity (3), as they share common pathophysiological mechanisms involving insulin resistance, heightened oxidative stress, perturbed hepatic glucose regulation, and impaired lipid metabolism (4–6). Here, INS is linked to type 2 diabetes mellitus.